Awarded

Mavacamten, Cobicistat/ Atazanavir, Fedratinib, Nivolumab, Abatacept, Luspatercept, Deucravacitinib, Ipilimumab y Ozanimod

Track this recordFree account — get alerted when a contract here runs out.
Contract value
no value published
Bids received
1
Published
30 Dec 2025
Awarded
29 Dec 2025
Contract start
29 Dec 2025
Contract end
30 Dec 2026estimated

More awards from this buyer